Get type 1 diabetes (T1D) communities involved in solving the problem and implementing T1D interventions in your country, said Tom Robinson, vice president of global access at JDRF.
Tom Robinson, vice president of global access at JDRF, goes over what policies are needed to implement and ensure access to 4 key type 1 diabetes (T1D) interventions: timely diagnosis, insulin and strips, pumps and continuous glucose monitors, and prevention and cures.
Transcript
What national or international policies are needed to ensure these interventions are implemented and accessible?
I'd say at the national level, there's ong thing that should be the number 1 policy priority for everybody, and that is to connect with and support local type 1 [diabetes] communities, both people living with type 1 [diabetes] and their health care [caretakers], because I can guarantee they have thought more about this than anybody else. We see them helping to pinpoint where the problem is; they're formidable problem solvers in their own right. Health care systems that work closely with those communities tend to be leading compared to other health care systems. So I think that's that's just a blanket thing like these are smart, committed, insurgent groups—get them involved in solving the problem in your country.
I think internationally there are probably a number of structures that we need to look at establishing to support that national level change. I think a clear strategy would be helpful. I think looking at philanthropic funding models and pooled models will be helpful. We need a consistently and widely used monitoring and evaluation capability so we can see change happening and see failure happening and success happening.
There's a few others. I don't want to get too far over my skis here because that's something we're working right now on with other major players, looking at these things and saying, "What do we need? What are the 5, 6, 7 things we need to establish internationally to support that national level change?" I think that's probably going to unfold in the next 6 to 12 months, so we might have another conversation about that then. I think there are some pretty exciting things coming out of that piece.
Dr Kathy Zackowski Discusses the Importance of Rehabilitation Research and Trials in MS
April 26th 2024Kathy Zackowski, PhD, National MS Society, expresses the inherent value of quality rehabilitation trials for broadening clinical understandings of multiple sclerosis (MS) and bettering patient outcomes.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More